Disease/Infection News

RSS

GSK awards milestone payment to Isis Pharmaceuticals to develop ISIS-GSK4Rx for ocular disease

Isis Pharmaceuticals, Inc. announced today that it has earned a $1.5 million milestone payment from GSK related to the advancement of the program to develop ISIS-GSK4Rx to treat an undisclosed ocular disease.

1 Oct 2014

Ardelyx announces positive Phase 2b results for tenapanor in IBS-C patients

Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced positive results from its 371 patient Phase 2b clinical trial evaluating tenapanor in patients with constipation-predominant irritable bowel syndrome (IBS-C).

1 Oct 2014

Bionic Vision Australia reports positive results of prototype implant in patients with RP-induced vision loss

Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).

1 Oct 2014

Rapid and coordinated response helps control Ebola outbreak in Nigeria

The Ebola outbreak in Nigeria appears to be nearing a possible end thanks to a rapid response coordinated by Nigeria's Emergency Operations Center with assistance from international partners, including the U.S. Centers for Disease Control and Prevention (CDC).

1 Oct 2014

Mission Pharmacal adds Ovace Plus Lotion to its range of product offerings

Itch. Scratch. Repeat. Irritating skin conditions, such as seborrheic dermatitis (SD), can create a distracting, uncomfortable vicious circle for those affected.

1 Oct 2014

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids.

30 Sep 2014

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.

30 Sep 2014

Rwanda is Ebola free, says Ministry of Health

The Ministry of Health would like to inform Rwandans and all visitors to Rwanda that Rwanda is Ebola free. The lab results of the patient who was reported in the media this past week were negative for the Ebola Virus Disease.

30 Sep 2014

Luminex gets FDA approval to add three new targets to xTAG Gastrointestinal Pathogen Panel

Luminex Corporation today announced it has received U.S. FDA clearance to add three new targets to its xTAG Gastrointestinal Pathogen Panel (GPP). The targets include Adenovirus 40/41, Entamoeba histolytica and Vibrio cholerae.

From Luminex 30 Sep 2014

UCSF gets CDC grant to provide expert guidance to clinicians who prescribe anti-HIV medications

The UCSF Clinician Consultation Center at San Francisco General Hospital and Trauma Center has been funded by the Centers for Disease Control and Prevention to provide a PrEPline, a telephone consultation service that gives expert guidance to healthcare providers across the nation who prescribe antiretroviral medications to HIV uninfected individuals to prevent HIV.

30 Sep 2014

Bridgestone Group to donate $1M to combat Ebola outbreak in Liberia

The Bridgestone Group (Bridgestone) today announced it will donate one million dollars (USD) to critical efforts underway in Liberia and the region to combat the Ebola outbreak.

30 Sep 2014

Seven NIH research contracts awarded to identify novel adjuvant candidates

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability.

30 Sep 2014

New approach to solve global challenges in food security, emerging diseases and biodiversity loss

Solving global challenges in food security, emerging diseases and biodiversity loss requires evolutionary thinking, argues a new study published online in Science Express that was co-authored by Bruce Tabashnik of the University of Arizona College of Agriculture and Life Sciences.

30 Sep 2014

Protein Sciences releases Flublok influenza vaccine for the 2014/2015 season

Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been released and are now available for shipment.

29 Sep 2014

New report urges nations to adopt improved data collection efforts for community health workers

A new report finds that developing nations' ability to deal with pressing health challenges like HIV/AIDS and ensuring maternal and newborn survival will be strengthened by creating a common definition for community health workers, as well as a core set of skills and competencies that would help ensure they are optimally trained, supported and deployed to provide care and treatment when and where it is needed most.

29 Sep 2014

Fecal microbiota transplantation officially recommended for effective treatment of C. difficile infection

The transplantation of faecal microbiota from a healthy donor has been shown in recent clinical studies to be a safe and highly effective treatment for recurrent Clostridium difficile (C. difficile) infection and is now recommended in European treatment guidelines.

29 Sep 2014

Study findings underscore huge public health challenge posed by severe periodontitis

The International and American Associations for Dental Research (IADR/AADR) have published a paper titled "Global Burden of Periodontitis: A Systematic Review and Meta-Regression."

29 Sep 2014

Save the Children-built Ebola treatment center opens doors in Liberia

A 70-bed Save the Children-built treatment center has now opened its doors in Liberia and is being run by the International Medical Corps.

29 Sep 2014

Canadian government committed to prevent, detect, and respond to infectious disease outbreaks

The Honourable Rona Ambrose, Minister of Health, committed to continued efforts to strengthen global health security at the Global Health Security Agenda (GHSA) meeting in Washington, DC.

27 Sep 2014

Prevalence of NTDs in Latin American countries presents opportunity for US foreign policy

Recently published prevalence estimates of neglected tropical diseases (NTDs) in five Latin American countries - Bolivia, Cuba, Ecuador, Nicaragua and Venezuela - could suggest a new direction for United States foreign policy in the region, according to a tropical-disease expert at Rice University's Baker Institute for Public Policy.

26 Sep 2014

Disease/Infection News

GSK awards milestone payment to Isis Pharmaceuticals to develop ISIS-GSK4Rx for ocular disease

Ardelyx announces positive Phase 2b results for tenapanor in IBS-C patients

Bionic Vision Australia reports positive results of prototype implant in patients with RP-induced vision loss

Rapid and coordinated response helps control Ebola outbreak in Nigeria

Mission Pharmacal adds Ovace Plus Lotion to its range of product offerings

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Mymetics' innovative HIV vaccine candidate to enter new preclinical trial

Rwanda is Ebola free, says Ministry of Health

Luminex gets FDA approval to add three new targets to xTAG Gastrointestinal Pathogen Panel

UCSF gets CDC grant to provide expert guidance to clinicians who prescribe anti-HIV medications

Bridgestone Group to donate $1M to combat Ebola outbreak in Liberia

Seven NIH research contracts awarded to identify novel adjuvant candidates

New approach to solve global challenges in food security, emerging diseases and biodiversity loss

Protein Sciences releases Flublok influenza vaccine for the 2014/2015 season

New report urges nations to adopt improved data collection efforts for community health workers

Fecal microbiota transplantation officially recommended for effective treatment of C. difficile infection

Study findings underscore huge public health challenge posed by severe periodontitis

Save the Children-built Ebola treatment center opens doors in Liberia

Canadian government committed to prevent, detect, and respond to infectious disease outbreaks

Prevalence of NTDs in Latin American countries presents opportunity for US foreign policy

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News